Notify me when Sarissa Capital Management LP files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 9 | $222,909,132 | +$11,806,610 | -$12,199,680 | -$393,070 | INVA, IRWD, NBIX, CYTK, AMRN | 13F-HR | 17 Feb 2026, 16:17 |
| Q3 2025 | 8 | $180,391,813 | +$7,963,207 | -$822,986 | +$7,140,221 | INVA, NBIX, CYTK, IRWD, AMRN | 13F-HR | 14 Nov 2025, 16:28 |
| Q2 2025 | 7 | $154,389,546 | +$20,153,788 | -$12,914,372 | +$7,239,416 | INVA, NBIX, AMRN, CYTK, IRWD | 13F-HR | 14 Aug 2025, 16:15 |
| Q1 2025 | 7 | $154,710,074 | +$3,611,200 | -$114,561,156 | -$110,949,956 | INVA, NBIX, CYTK, IRWD, AMRN | 13F-HR | 15 May 2025, 16:16 |
| Q4 2024 | 8 | $322,862,731 | +$3,310,020 | -$78,644,556 | -$75,334,536 | INVA, IRWD, NBIX, CYTK, GILD | 13F-HR | 14 Feb 2025, 16:18 |
| Q3 2024 | 10 | $402,327,041 | +$2,853,500 | -$154,678,414 | -$151,824,914 | INVA, IRWD, GILD, CYTK, NBIX | 13F-HR | 14 Nov 2024, 16:06 |
| Q2 2024 | 10 | $592,420,772 | +$52,704,527 | $0 | +$52,704,527 | BIIB, INVA, IRWD, GILD, CYTK | 13F-HR | 14 Aug 2024, 16:30 |
| Q1 2024 | 10 | $571,629,246 | +$23,553,730 | -$17,043,326 | +$6,510,404 | IRWD, BIIB, INVA, GILD, NBIX | 13F-HR | 15 May 2024, 16:43 |
| Q4 2023 | 9 | $648,896,720 | +$40,142,448 | -$197,950,522 | -$157,808,074 | IRWD, BIIB, INVA, GILD, NBIX | 13F-HR | 14 Feb 2024, 16:31 |
| Q3 2023 | 11 | $742,379,576 | +$20,243,607 | -$198,653,661 | -$178,410,054 | ALKS, BIIB, IRWD, INVA, GILD | 13F-HR | 14 Nov 2023, 16:30 |
| Q2 2023 | 11 | $1,004,526,158 | +$194,536,076 | -$3,967,350 | +$190,568,726 | ALKS, BIIB, IRWD, INVA, GILD | 13F-HR | 14 Aug 2023, 16:30 |
| Q1 2023 | 11 | $781,897,166 | +$154,500 | -$20,671,501 | -$20,517,001 | ALKS, BIIB, IRWD, INVA, GILD | 13F-HR | 15 May 2023, 16:49 |
| Q4 2022 | 11 | $840,211,867 | $0 | -$178,096,277 | -$178,096,277 | ALKS, IRWD, BIIB, GILD, INVA | 13F-HR | 14 Feb 2023, 16:29 |
| Q3 2022 | 11 | $884,819,000 | $0 | -$6,287,773 | -$6,287,773 | ALKS, BIIB, IRWD, GILD, INVA | 13F-HR | 14 Nov 2022, 16:33 |
| Q2 2022 | 11 | $993,488,000 | +$383,000 | -$14,657,330 | -$14,274,330 | ALKS, IRWD, BIIB, INVA, GILD | 13F-HR | 15 Aug 2022, 17:26 |
| Q1 2022 | 11 | $1,057,966,000 | +$15,627,500 | -$121,923,320 | -$106,295,820 | ALKS, IRWD, BIIB, INVA, GILD | 13F-HR | 16 May 2022, 16:48 |
| Q4 2021 | 11 | $1,155,293,000 | +$60,129,428 | -$5,663,578 | +$54,465,850 | ALKS, GILD, IRWD, BIIB, INVA | 13F-HR | 14 Feb 2022, 16:55 |
| Q3 2021 | 10 | $1,273,975,000 | +$109,732,191 | -$129,650,918 | -$19,918,727 | ALKS, IRWD, GILD, BIIB, INVA | 13F-HR | 15 Nov 2021, 17:00 |
| Q2 2021 | 14 | $1,257,696,000 | +$96,118,268 | -$53,385,302 | +$42,732,966 | ALKS, BIIB, IRWD, GILD, ALXN | 13F-HR | 16 Aug 2021, 17:00 |
| Q1 2021 | 14 | $1,043,262,000 | +$248,528,556 | -$180,032,179 | +$68,496,377 | IRWD, BIIB, GILD, ALKS, ALXN | 13F-HR | 17 May 2021, 17:04 |
| Q4 2020 | 12 | $974,781,000 | +$29,577,624 | -$29,053,842 | +$523,782 | IRWD, ALKS, BIIB, JAZZ, ALXN | 13F-HR | 16 Feb 2021, 16:05 |
| Q3 2020 | 11 | $849,434,000 | +$24,182,602 | -$30,450,000 | -$6,267,398 | BIIB, JAZZ, ALKS, IRWD, ALXN | 13F-HR | 16 Nov 2020, 16:05 |
| Q2 2020 | 12 | $898,918,000 | +$143,954,945 | -$110,406,000 | +$33,548,945 | BIIB, ALKS, IRWD, JAZZ, INVA | 13F-HR | 14 Aug 2020, 16:11 |
| Q1 2020 | 12 | $783,828,000 | +$144,084,856 | -$425,294,000 | -$281,209,144 | BIIB, IRWD, ALKS, AGN, JAZZ | 13F-HR | 15 May 2020, 16:03 |
| Q4 2019 | 13 | $1,204,783,000 | +$179,909,126 | -$125,175,551 | +$54,733,575 | MDCO, BIIB, IRWD, ICPT, AGN | 13F-HR | 14 Feb 2020, 16:15 |
| Q3 2019 | 12 | $797,914,000 | +$15,373,220 | -$2,862,000 | +$12,511,220 | MDCO, AGN, BIIB, IRWD, INVA | 13F-HR | 14 Nov 2019, 16:25 |
| Q2 2019 | 13 | $802,161,000 | +$158,186,226 | $0 | +$158,186,226 | AGN, MDCO, BIIB, IRWD, INVA | 13F-HR | 14 Aug 2019, 16:26 |
| Q1 2019 | 11 | $664,251,000 | +$183,588,711 | -$174,000 | +$183,414,711 | AGN, BIIB, IRWD, MDCO, INVA | 13F-HR | 15 May 2019, 16:02 |
| Q4 2018 | 10 | $451,249,000 | +$109,775,398 | -$23,542,278 | +$86,233,120 | BIIB, INVA, AGN, IRWD, MDCO | 13F-HR | 14 Feb 2019, 16:14 |
| Q3 2018 | 9 | $453,306,000 | $0 | -$104,049,781 | -$104,049,781 | BIIB, INVA, AGN, IRWD, MDCO | 13F-HR | 14 Nov 2018, 16:29 |
| Q2 2018 | 10 | $498,793,000 | +$33,592,693 | -$1,855,000 | +$31,737,693 | BIIB, MDCO, IRWD, INVA, AGN | 13F-HR | 14 Aug 2018, 16:43 |
| Q1 2018 | 11 | $432,144,000 | +$108,391,317 | -$71,082,000 | +$37,309,317 | BIIB, MDCO, INVA, AGN, IRWD | 13F-HR | 15 May 2018, 16:42 |
| Q4 2017 | 11 | $390,650,000 | +$156,389,213 | -$67,903,000 | +$88,486,213 | BIIB, BIVV, MDCO, INVA, AGN | Restatement | 23 Feb 2018, 16:30 |
| Q3 2017 | 9 | $323,993,000 | +$11,147,171 | $0 | +$11,147,171 | BIIB, BIOVERATIV INC, MDCO, INVA, ACHN | 13F-HR | 14 Nov 2017, 17:22 |
| Q2 2017 | 8 | $299,557,000 | +$90,980,994 | -$17,771,000 | +$73,209,994 | BIIB, BIOVERATIV INC, MDCO, INVA, NVLNF | 13F-HR | 14 Aug 2017, 16:19 |
| Q1 2017 | 11 | $253,055,000 | +$14,664,401 | -$161,571,796 | -$146,907,395 | MDCO, BIIB, INVA, NVLNF, BIVV | 13F-HR | 15 May 2017, 16:37 |
| Q4 2016 | 11 | $363,082,000 | +$31,644,168 | -$67,742,824 | -$36,098,656 | ARIA, BIIB, MDCO, INVA, NVLNF | 13F-HR | 14 Feb 2017, 16:18 |
| Q3 2016 | 14 | $434,231,000 | +$10,990,000 | -$42,494,454 | -$31,504,454 | ARIA, BIIB, MDCO, ARRY, PCRX | 13F-HR | 14 Nov 2016, 16:36 |
| Q2 2016 | 15 | $352,312,000 | +$23,975,727 | -$141,228,585 | -$117,252,858 | ARIA, BIIB, MDCO, ITCI, PCRX | 13F-HR | 15 Aug 2016, 16:46 |
| Q1 2016 | 16 | $453,821,000 | +$32,578,259 | -$16,009,000 | +$16,569,259 | ABBV, ARIA, BIIB, MDCO, DGX | 13F-HR | 16 May 2016, 16:13 |
| Q4 2015 | 17 | $514,358,000 | +$112,425,679 | -$24,015,927 | +$88,409,752 | BIIB, ABBV, ARIA, MDCO, DGX | 13F-HR | 16 Feb 2016, 16:06 |
| Q3 2015 | 18 | $404,891,000 | +$52,649,055 | -$16,973,444 | +$35,675,611 | ABBV, ARIA, MDCO, DGX, AEGR | 13F-HR | 16 Nov 2015, 16:25 |
| Q2 2015 | 16 | $434,562,000 | +$11,776,147 | -$48,799,547 | -$37,023,400 | ARIA, ABBV, DGX, MDCO, AEGR | 13F-HR | 14 Aug 2015, 17:20 |
| Q1 2015 | 17 | $474,075,000 | +$195,399,872 | -$31,634,000 | +$163,765,872 | ARIA, ABBV, DGX, AMGN, AEGR | 13F-HR | 14 May 2015, 18:07 |
| Q4 2014 | 16 | $282,531,000 | +$37,297,629 | -$34,277,785 | +$3,019,844 | ARIA, DGX, AMGN, MRK, A | 13F-HR | 17 Feb 2015, 11:02 |
| Q3 2014 | 14 | $258,936,000 | +$46,095,309 | -$52,073,000 | -$5,977,691 | ARIA, DGX, BRLI, A, MRK | 13F-HR | 13 Nov 2014, 19:50 |
| Q2 2014 | 15 | $294,075,000 | +$20,556,670 | -$90,938,410 | -$70,381,740 | ARIA, IDIX, DGX, BRLI, MRK | 13F-HR | 14 Aug 2014, 15:47 |
| Q1 2014 | 15 | $290,423,000 | +$47,387,179 | -$39,372,706 | +$8,014,473 | ARIA, DGX, BRLI, IDIX, MRK | 13F-HR | 15 May 2014, 11:29 |
| Q4 2013 | 12 | $267,017,000 | $0 | $0 | $0 | ARIA, DGX, IDIX, VVUS, MRK | 13F-HR | 14 Feb 2014, 09:45 |